Literature DB >> 22042352

[Ten-year follow-up of kidney transplantation with living unrelated donor].

Gustavo Fernandes Ferreira1, Igor Denizarde Bacelar Marques, Clarice Hyesuk Lee Park, David José de Barros Machado, Francine Brambate Carvalhinho Lemos, Flávio Jota de Paula, William Carlos Nahas, Elias David-Neto.   

Abstract

INTRODUCTION: In the current era of scarcity of kidneys available for transplantation, and chronic anti-HLA-mediated rejection as a main cause of graft loss, continuous demonstration of the long-term survival of grafts from living unrelated kidney donors (LURD) is paramount.
OBJECTIVE: Analyze long-term kidney graft and patient outcomes using LURD, and compare them with living related donors (LRD).
METHODS: We analyzed the 389 first renal transplantations performed with a living donor (281 LRD and 108 LURD), in a single center, from January 1998 through December 2007.
RESULTS: There were no significant differences between LRD and LURD as refers to patient survival (89.1% vs. 84.7%, p = 0.40, respectively) and graft survival (81.1% vs. 68.9%, p = 0.77, respectively), 10 years post-transplantation. On Cox proportional regression model of multivariate analysis, panel reactive antibodies (PRA) > 10% and the occurrence of acute rejection in the first year posttransplantation were the only independent predictors of graft loss (HR 2.54, 95% CI 1.35 -4.78; p < 0.05 and HR 4.1, 95% CI 2.04 - 4.78; p < 0.05, respectively).
CONCLUSION: LURD are an important source of organs for renal transplantation, with results similar to those obtained with LRD, regardless of HLA matching.

Entities:  

Mesh:

Year:  2011        PMID: 22042352     DOI: 10.1590/s0101-28002011000300011

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  1 in total

1.  Increasing transplantability in Brazil: time to discuss Kidney Paired Donation.

Authors:  Juliana Bastos; David José de Barros Machado; Elias David-Neto
Journal:  J Bras Nefrol       Date:  2022 Jul-Sep
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.